Skip to search formSkip to main contentSkip to account menu

Arbaclofen

Known as: Baclofen R-, d-Baclofen, (R)-(-)-Baclofen 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

STX209

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A MEG Study of Acute Arbaclofen (STX-209) Administration
Several electrophysiological parameters, including the auditory evoked response component M50/M100 latencies and the phase… 
2017
2017
Nonmedical use of prescription drugs in adolescents and young adults: not just a Western phenomenon
onists have been tested in ASD associated with fragile X syndrome, and showed promise in a subgroup of patients. GABAergic agents… 
Review
2013
Review
2013
Pain: morphine, metabolites, mambas, and mutations
2013
2013
Randomized, Controlled, Phase 2 Trial of STX209 (Arbaclofen) for Social Function in ASD
2013
2013
Billions spent on rare diseases
volume 31 NumBeR 5 mAY 2013 nature biotechnology is considered to be a key aspect of synaptic plasticity. Individuals with FXS… 
2012
2012
TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.
Review
2012
Review
2012
Autism spectrum disorders
Nature Reviews Drug Discovery 11, 745–746 (2012) There were some inaccuracies in the description of the compound STX-209… 
2012
2012
Trialing targeted therapies for autism
study identified a complete loss of synaptic retinoic acid signaling and associated homeostatic plasticity in FXS mice 5 . It is… 
Review
2011
Review
2011
ACS chemical neuroscience molecule spotlight on STX209 (arbaclofen).
STX209 (arbaclofen) is a γ-amino butyric acid type B (GABA(B)) receptor agonist from Seaside Therapeutics currently in clinical… 
2009
2009
490 Arbaclofen Placarbil Monotherapy Decreases GERD Symptoms in Subjects with Previous PPI Therapy
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)